01:38 PM EST, 12/19/2024 (MT Newswires) -- Health care stocks were declining Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.

The iShares Biotechnology ETF (IBB) fell 1.1%.

In corporate news, Eli Lilly's ( LLY ) tirzepatide injection products Zepbound and Mounjaro are no longer in shortage, the US Food and Drug Administration said Thursday. Eli Lilly ( LLY ) shares were down 0.7%.